Page last updated: 2024-08-26

imipenem, anhydrous and Coronary Disease

imipenem, anhydrous has been researched along with Coronary Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alter, P; Maisch, B; Schaefer, JR1

Other Studies

1 other study(ies) available for imipenem, anhydrous and Coronary Disease

ArticleYear
[Impediment of cellular immune response under treatment with ticlopidine in a patient with Staphylococcus aureus endocarditis].
    Zeitschrift fur Kardiologie, 2000, Volume: 89, Issue:8

    Topics: Agranulocytosis; Angioplasty, Balloon, Coronary; Anti-Bacterial Agents; Clarithromycin; Coronary Disease; Drug Therapy, Combination; Echocardiography, Doppler; Endocarditis, Bacterial; Fibrinolytic Agents; Gentamicins; Humans; Imipenem; Immunity, Cellular; Leukocyte Count; Leukocytes; Leukopenia; Male; Middle Aged; Platelet Aggregation Inhibitors; Staphylococcal Infections; Thienamycins; Ticlopidine; Time Factors; Vancomycin

2000